Cytori appoints Tommy Thompson to board and names Lloyd Dean chairman
This article was originally published in Scrip
Executive Summary
Cytori Therapeutics has elected the Honourable Tommy Thompson, former secretary of the US Department of Health & Human Services and Governor of Wisconsin, as an independent member of its board of directors. The company has also named Lloyd Dean chairman of the board; he is president and CEO of Catholic Healthcare West, the largest not-for-profit hospital provider in California. Cytori's past chairman, Ronald Henriksen, will continue to serve as an independent member of the board of directors.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.